Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics
- 11 July 2012
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 4 (142) , 142ra94
Abstract
A compendium of SRM assays for cancer-associated proteins provides a resource for accelerating and planning biomarker verification studies.Keywords
This publication has 80 references indexed in Scilit:
- Reactome pathway analysis to enrich biological discovery in proteomics data setsProteomics, 2011
- Depletion of Abundant Plasma Proteins and Limitations of Plasma ProteomicsJournal of Proteome Research, 2010
- Perspectives of targeted mass spectrometry for protein biomarker verificationCurrent Opinion in Chemical Biology, 2009
- Prediction of high-responding peptides for targeted protein assays by mass spectrometryNature Biotechnology, 2009
- Concentration and preservation of very low abundance biomarkers in urine, such as human growth hormone (hGH), by Cibacron Blue F3G-A loaded hydrogel particlesNano Research, 2008
- Targeted proteomic strategy for clinical biomarker discoveryMolecular Oncology, 2008
- Selected reaction monitoring for quantitative proteomics: a tutorialMolecular Systems Biology, 2008
- The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipelineProteomics – Clinical Applications, 2008
- Smart Hydrogel Particles: Biomarker Harvesting: One-Step Affinity Purification, Size Exclusion, and Protection against DegradationNano Letters, 2007
- Network‐based classification of breast cancer metastasisMolecular Systems Biology, 2007